Cost-effectiveness analysis of etanercept in the treatment of rheumatoid arthritis in Portugal

Health Research

Text available via DOI:

https://doi.org/10.1016/j.jval.2014.08.2616
Final published version

Research output: Contribution to Journal/Magazine › Meeting abstract › peer-review

Published

Standard

Cost-effectiveness analysis of etanercept in the treatment of rheumatoid arthritis in Portugal. / Caixeiro Mateus, Ceu; Moura, A.
In: Value in Health, Vol. 17, No. 7, 11.2014, p. A380-A381.

Research output: Contribution to Journal/Magazine › Meeting abstract › peer-review

Bibtex

@article{8cf9829c1caa491ea4a866f3f479bae6,

title = "Cost-effectiveness analysis of etanercept in the treatment of rheumatoid arthritis in Portugal",

abstract = "The present study aims to estimate the cost-effectiveness of etanercept compared to golimumab in the treatment of patients with Rheumatoid Arthritis (RA) in Portugal.",

author = "{Caixeiro Mateus}, Ceu and A. Moura",

year = "2014",

month = nov,

doi = "10.1016/j.jval.2014.08.2616",

language = "English",

volume = "17",

pages = "A380--A381",

journal = "Value in Health",

issn = "1098-3015",

publisher = "ELSEVIER SCIENCE INC",

number = "7",

}

RIS

TY - JOUR

T1 - Cost-effectiveness analysis of etanercept in the treatment of rheumatoid arthritis in Portugal

AU - Caixeiro Mateus, Ceu

AU - Moura, A.

PY - 2014/11

Y1 - 2014/11

N2 - The present study aims to estimate the cost-effectiveness of etanercept compared to golimumab in the treatment of patients with Rheumatoid Arthritis (RA) in Portugal.

AB - The present study aims to estimate the cost-effectiveness of etanercept compared to golimumab in the treatment of patients with Rheumatoid Arthritis (RA) in Portugal.

U2 - 10.1016/j.jval.2014.08.2616

DO - 10.1016/j.jval.2014.08.2616

M3 - Meeting abstract

VL - 17

SP - A380-A381

JO - Value in Health

JF - Value in Health

SN - 1098-3015

IS - 7

ER -

Research

Links

Text available via DOI: